Stryker's spine robot has been in development for years, and its launch is expected in the near future. Here's what we know so far: 1. In 2022 Stryker CEO Kevin Lobo said in a third quarter earnings ...

Stryker showcased positive performance, achieving a revenue growth rate of 11.92% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. When compared to ...

Ortho and surgery tech giant Stryker sold its former headquarters site in Kalamazoo, Michigan for $3.5 million, according to ...

We recently published a list of 8 Most Promising Robotics Stocks According to Hedge Funds. In this article, we are going to ...

Stryker Corporation SYK reported third-quarter 2024 adjusted earnings per share (EPS) of $2.87, which beat the Zacks ...

Stryker (NYSE:SYK) today announced the launch of the next generation of SurgiCount+ within its sponge management portfolio.

FLOWER MOUND, Texas, USA, Nov. 19, 2024 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, unveiled the Oculan Lighting Platform, an innovative lighting solution designed to ...

Stryker (SYK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Larry Biegelsen ...

Portage-based medical technology company Stryker Corp. has sold its former headquarters in Kalamazoo to an affiliate of ...

Stryker Trading Down 2.0 % Shares of NYSE:SYK opened at $352.82 on Monday. Stryker has a 12-month low of $255.22 and a 12-month high of $374.63. The company has a quick ratio of 0.95, a current ...

Bank of America Securities analyst Travis Steed maintained a Buy rating on Stryker (SYK – Research Report) today. The company’s shares opened today at $386.67. Steed covers the Healthcare sector, ...

Our Morningstar Uncertainty Rating for Stryker is Medium, reflecting the company's widely diversified product lineup in categories that are relatively insulated from macroeconomic conditions.